Close
Help
Need Help?



Most Highly Accessed Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders Articles in September 2012

Posted Sun, Oct, 07,2012

These articles were the most highly accessed articles in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders in September 2012:Dupuytren's Contracture in Alabama HFE Hemochromatosis Probands (accessed 373 times)James C. Barton, and J. Clayborn BartonHylan G-F 20: Review of its Safety and Efficacy in the Management of Joint Pain in Osteoarthritis (accessed 344 times)A. Migliore,...

Continue Reading →

Most Highly Accessed Clinical Medicine Insights: Case Reports Articles in September 2012

Posted Sun, Oct, 07,2012

These articles were the most highly accessed articles in Clinical Medicine Insights: Case Reports in September 2012:Gait Balance Disorder by Thalamic Infarction with the Disorder of Interstitial Nucleus of Cajal (accessed 715 times)A. Kurosu, Y. Hayashi, K. Wada and M. NagaokaTriad of Iron Deficiency Anemia, Severe Thrombocytopenia and Menorrhagia—A Case Report and Literature Review (accesse...

Continue Reading →

Most Highly Accessed Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine Articles in September 2012

Posted Sun, Oct, 07,2012

These articles were the most highly accessed articles in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine in September 2012:Omalizumab: Clinical Use for the Management of Asthma (accessed 287 times)Neil C. Thomson and Rekha ChaudhuriThe Respiratory Exchange Ratio is Associated with Fitness Indicators Both in Trained and Untrained Men: A Possible Application for People wi...

Continue Reading →

Most Highly Accessed Clinical Medicine Insights: Endocrinology and Diabetes Articles in September 2012

Posted Sun, Oct, 07,2012

These articles were the most highly accessed articles in Clinical Medicine Insights: Endocrinology and Diabetes in September 2012:Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin? (accessed 458 times)Sami N. Nasrallah and L. Raymond ReynoldsRosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia (accessed ...

Continue Reading →

Most Highly Accessed Drug Target Insights Articles in September 2012

Posted Sun, Oct, 07,2012

These articles were the most highly accessed articles in Drug Target Insights in September 2012:17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells (accessed 384 times)Upasana Sarangi, Khande Rao Paithankar, Jonnala Ujwal Kumar, Vaidyanathan Subramaniam and Amere Subbarao SreedharTargeting Receptors, Transporters and Site of...

Continue Reading →

Most Highly Accessed Evolutionary Bioinformatics Articles in September 2012

Posted Sun, Oct, 07,2012

These articles were the most highly accessed articles in Evolutionary Bioinformatics in September 2012:Cloud Computing for Comparative Genomics with Windows Azure Platform (accessed 790 times)Insik Kim, Jae-Yoon Jung, Todd F. DeLuca, Tristan H. Nelson and Dennis P. WallReliable Phylogenetic Trees Building: A New Web Interface for FIGENIX (accessed 573 times)Julien Paganini and Philippe GouretPhylo...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
As the Editor-in-Chief of Clinical Medicine Insights: Trauma and Intensive Medicine, I experience an outstanding professional and timely support by the publisher, Libertas Academica, in all editorial matters.
Dr Philip F. Stahel (Denver Health Medical Center, University of Colorado Denver, School of Medicine, Denver, CO, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results